Nathan J Dowden Entrada Therapeutics, Inc. (TRDA) insider trading activity
Nathan J Dowden is President & COO of Entrada Therapeutics, Inc.. Currently has a direct ownership of 180,805 shares of TRDA, which is worth approximately $1.63 Million. The most recent transaction as insider was on Oct 24, 2022, when has been sold 2,404 shares (Common Stock) at a price of $19.27 per share, resulting in proceeds of $46,325. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
181K
44.47%
3M change
31.78%
12M change
Total Value Held
$1.63 Million
Nathan J Dowden Transaction History
NJD
Nathan J Dowden
President & COO
Boston, MA